<DOC>
	<DOCNO>NCT02540213</DOCNO>
	<brief_summary>This non-interventional , observational study investigates efficiency , safety acceptance MIRCERA participant , receive erythropoiesis stimulate agent ( ESA ) use self-application system . For participant , investigator document 9 month treatment Mircera respect efficacy , safety acceptance .</brief_summary>
	<brief_title>Observational Study MIRCERA Users Self-Application Multidose Systems</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Anemia cause CKD Life expectancy ( &gt; ) 9 month judgment attend physician Ferritin &gt; 200 microgram per liter ( mcg/L ) accordance relevant guideline The time point change Mircera 3 month ago long</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>